Treatment type: Cell therapies

Hudson Institute researchers have pioneered 3D bioprinted degradable meshes with stem cells for the treatment of pelvic organ prolapse (POP), in the hope of providing a safe, effective solution for millions of women worldwide.…  Read more

There is a major gap in the rapidly growing cell therapy industry: qualified staff who can undertake the cell manufacturing needed as part of the therapy. …  Read more

Hudson Institute has created a new program for young women designed to encourage them to consider a career in medical research.

The inaugural Hudson Institute of Young Women in Science program was funded as part of a concerted effort by the federal government to increase the number of women in science.…  Read more

Every 15 hours, a baby is born with cerebral palsy – a condition that comes with life-long disability and has no cure.…  Read more

A world‐first safety trial is underway examining amniotic stem cells as therapy for acute stroke. The study is a partnership between Hudson Institute of Medical Research, Monash Health and La Trobe University.…  Read more

A safer and more effective treatment for women with pelvic organ prolapse (POP) may be on the horizon, thanks to a new technique that uses a woman’s own stem cells to boost the effectiveness of a degradable mesh. A study published in Biomacromolecules, led by Dr Shayanti Mukherjee, shows how a degradable mesh, made from…  Read more

Hudson Institute’s Cancer Genetics and Functional Genomics Postdoctoral Scientist, Dr Marius Dannappel, has been awarded a highly sought after Research Fellowship from the DFG (German Research Foundation) that will progress his research aimed at developing treatments for colorectal cancer. The two year early career fellowship will enable Dr Dannappel to continue his research into the…  Read more

Scientists are demonstrating how the womb’s unique ability to rapidly rebuild itself could be harnessed to heal difficult-to-repair chronic wounds affecting 400,000 Australians.…  Read more

Lung fibrosis patients could soon inhale ‘droplets’ of tiny particles derived from stem-like cells found in the human placenta in an effort to repair ‘irreversible’ deadly scarring of the lungs, thanks to world-first research. The regenerative medicine treatment could one day form an alternative for patients with the disease who aren’t eligible for a life-saving…  Read more

A world-first therapy, developed at Hudson Institute of Medical Research and Monash University, using cells from the human placenta to repair the damaged lungs of premature babies, is giving hope to families of the most fragile infants like Harry Campbell. The results of a clinical trial at the Monash Children’s Hospital – the culmination of…  Read more